Exploring
Arterial Stifness

As a new cardiovascular Imaging biomarkers

Through advanced MRI acquisition

About US

Imageens is a research project leveraging MRI-derived arterial stiffness biomarkers to address unmet medical needs by unlocking the full potential of cardiovascular imaging data.

Starting off in cardiovascular prevention, we use our imaging biomarkers across various clinical areas, with the mission to transform and save patients’ lives.

Learn more About Us
Technology

Meet
ArtFun+

ArtFun+ is a clinically-validated technology for measuring new predictive imaging biomarkers of cardiovascular events.
Learn more About the Technology
Technology

MRI-based
Precision Biomarkers

ArtFun+ measures novel MRI biomarkers based on arterial stiffness evaluation that are recognized as a major risk factor for cardiovascular diseases and significant predictors of mortality.
Learn more About the Technology
Technology

Detecting Early
Vascular Aging

ArtFun+ biomarkers predict and detect earliest sign of cardiovascular diseases across large at-risk and asymptomatic patients populations.
Learn more About the Technology
Technology

Most Clinically
Validated

ArtFun+ is the most published technology for measuring arterial stiffness by MRI. It was validated in a range of clinical application that increased the understanding of CV diseases.
Learn more About the Technology
Science

Meet
ArtFun+

ArtFun+ is a MDR CE class IIa and clinically-validated technology for measuring new predictive imaging biomarkers of cardiovascular events.
Science

MRI-based
Precision Biomarkers

ArtFun+ measures novel MRI biomarkers based on arterial stiffness evaluation that are recognized as a major risk factor for cardiovascular diseases and significant predictors of mortality.
Science

Detecting Early
Vascular Aging

ArtFun+ biomarkers predict and detect earliest sign of cardiovascular diseases across large at-risk and asymptomatic patients populations.
Science

Most Clinically
Validated

ArtFun+ is the most published technology for measuring arterial stiffness by MRI. It was validated in a range of clinical application that increased the understanding of CV diseases.
Learn more About the Science
Technology

Meet
ArtFun+

ArtFun+ is a clinically-validated technology for measuring new predictive imaging biomarkers of cardiovascular events.
Technology

MRI-based
Precision Biomarkers

ArtFun+ measures novel MRI biomarkers based on arterial stiffness evaluation that are recognized as a major risk factor for cardiovascular diseases and significant predictors of mortality.
Technology

Detecting Early
Vascular Aging

ArtFun+ biomarkers predict and detect earliest sign of cardiovascular diseases across large at-risk and asymptomatic patients populations.
Technology

Most Clinically
Validated

ArtFun+ is the most published technology for measuring arterial stiffness by MRI. It was validated in a range of clinical application that increased the understanding of CV diseases.
primary prevention

Our first positioning led to a new mode for monitoring cardio-vascular check-ups.

beyond primary prevention

Beyond primary prevention, we are using our cardiovascular imaging biomarkers to tackle a wider range of clinical applications.

Vascular
Diseases
Cardiac
Diseases
Brain
Diseases
Further
Diseases

We are also sharing our science and approach to
support the development of new research projects.

Trusted by over 60 of the World’s Leading Clinical Centers across 13 countries for their research or clinical practice.

Rooted in Scientific Excellence

10+
Years of R&D
77+
Scientific Papers
2M+
Medical Images
See Clinical Evidence

Featured in